Christophe L. M. J. Verlinde

Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase

Frederick S. Buckner, Christophe L. M. J. Verlinde, Anne Camille La Flamme et al. · Antimicrobial Agents and Chemotherapy · 1996 · 525 citations · Full text

Parasitic Disease, Antiparasitic Agent, Malaria +16

Five Members of a Novel Ca2+-binding Protein (CABP) Subfamily with Similarity to Calmodulin

Françoise Haeseleer, Izabela Sokal, Christophe L. M. J. Verlinde et al. · Journal of Biological Chemistry · 2000 · 261 citations · Full text

Missense Mutations in the Regulatory Domain of PKCγ: A New Mechanism for Dominant Nonepisodic Cerebellar Ataxia

Dong-Hui Chen, Zoran Brkanac, Christophe L. M. J. Verlinde et al. · The American Journal of Human Genetics · 2003 · 238 citations · Full text

Neurodegenerative Diseases, Regulatory Domain, Molecular Neuroscience +10

High-Affinity Pentavalent Ligands of <i>Escherichia coli</i> Heat-Labile Enterotoxin by Modular Structure-Based Design

Erkang Fan, Zhongsheng Zhang, Wendy E. Minke et al. · Journal of the American Chemical Society · 2000 · 209 citations

Microbial Toxin, Heat-labile Enterotoxin, Engineering +15

Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors

Kayode K. Ojo, E.T. Larson, Katelyn R. Keyloun et al. · Nature Structural & Molecular Biology · 2010 · 184 citations · Full text

Selective Kinase Inhibitors, Signal Transduction, Signaling Pathway +6